Circulating Microparticles Decrease After Cardiac Stress in Patients With Significant Coronary Artery Stenosis

Jan-Malte Sinning1, Felix Jansen2, Christoph Hammerstingl2

  • 1Department of Medicine II, Heart Center Bonn, University Hospital Bonn, Bonn, Germany. jan-malte.sinning@ukb.uni-bonn.de.

Clinical Cardiology
|July 14, 2016
PubMed

Insights

Cardiac ischemia reduces circulating microparticles (MPs) during stress in patients with coronary stenosis. Increased endothelial uptake capacity may explain this reduction, offering insights into cardiovascular disease mechanisms.

Area of Science:

  • Cardiovascular Medicine
  • Biomarkers
  • Echocardiography

Background:

  • Circulating microparticles (MPs) increase with cardiac stress in healthy individuals but are diminished in vascular disease.
  • The effect of coronary ischemia on circulating MP levels was previously unknown.
  • This study investigated MP kinetics during cardiac stress in patients with coronary artery stenosis.

Purpose of the Study:

  • To determine if patients with significant coronary stenosis exhibit altered circulating MP levels following cardiac stress.
  • To explore the relationship between coronary artery stenosis severity and MP dynamics.
  • To identify potential mechanisms behind observed MP level changes.

Main Methods:

  • Eighty patients with stable coronary artery disease underwent dobutamine stress echocardiography (DSE).
  • Blood samples were collected pre-DSE, immediately post-DSE, and at 4 and 24 hours to measure endothelial microparticles (EMPs), monocyte-derived microparticles (MMPs), and platelet microparticles.
  • Significant stenosis was defined as ≥70% diameter reduction in a major epicardial coronary artery.

Main Results:

  • Forty-one patients had significant coronary artery stenoses.
  • In these patients, CD144+ EMPs and CD14+CD16+ MMPs decreased immediately after DSE.
  • Patient sera augmented endothelial cells' capacity to uptake EMPs in vitro, linked to enhanced endothelial phosphatidylserine receptor expression.

Conclusions:

  • Cardiac ischemia results in reduced circulating MP levels during cardiac stress.
  • Altered endothelial microparticle uptake capacities represent a potential mechanism for these observed changes.
  • Findings suggest a novel role for MP dynamics in the pathophysiology of coronary artery disease.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
710
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.4K
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.1K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.1K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
384
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
894